Signs of hypoglycemia may include dizziness and lightheadedness
Next-generation obesity drugs are exploring combinations of GLP-1 with other entero-pancreatic hormones, such as GIP, glucagon, and amylin, to amplify weight loss and cardiometabolic benefits
No regulatory body classifies this as a contraindicated pair
Previous research shows the Now, researchers from Brigham and Womens Hospital and Massachusetts General Hospital have found that a type of medication called sodium-glucose contratransporter 2 (SGLT2) inhibitors used to treat type 2 diabetes may help lower a persons risk of developing kidney stones
It's crucial to inform your healthcare provider about any existing health conditions, medications, or supplements you're taking to ensure the treatment is safe for you
It is being heralded as a breakthrough treatment for many people who struggle with chronic weight management